An optimized Breast Cancer Index node-positive (BCIN plus ) prognostic model for late distant recurrence in patients with hormone receptor-positive (HR plus ) node-positive breast cancer

被引：2
|
作者：
Liefers, G-J. [1 ]
Noordhoek, I. [1 ]
Zhang, Y. [2 ]
Sgroi, D. C. [3 ]
Putter, H. [1 ]
Treuner, K. [2 ]
Wong, J. [2 ]
Kranenbarg, E. Meershoek-Klein [1 ]
Duijm-De Carpentier, M. [1 ]
van de Velde, C. [1 ]
Schnabel, C. A. [2 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Biotheranostics Inc, San Diego, CA USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.03.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7P
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [41] Micrometastatic node-positive breast cancer: An analysis of outcomes in comparison to node-negative and macrometastatic node-positive disease
    Truong, P. T.
    Li, K.
    Lesperance, M.
    Chia, S.
    Macfarlane, R.
    Speers, C. H.
    Olivotto, I. A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S17 - S17
  • [42] Chemotherapy for older women with node-positive breast cancer
    Ginsburg, D
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2001, 165 (05) : 525 - +
  • [43] Modelling the effects of standard prognostic factors in node-positive breast cancer
    W Sauerbrei
    P Royston
    H Bojar
    C Schmoor
    M Schumacher
    [J]. British Journal of Cancer, 1999, 79 : 1752 - 1760
  • [44] Modelling the effects of standard prognostic factors in node-positive breast cancer
    Sauerbrei, W
    Royston, P
    Bojar, H
    Schmoor, C
    Schumacher, M
    [J]. BRITISH JOURNAL OF CANCER, 1999, 79 (11-12) : 1752 - 1760
  • [45] Radiotherapy or surgery for the axilla in node-positive breast cancer?
    Farace, Paolo
    Deidda, Maria Assunta
    Amichetti, Maurizio
    [J]. LANCET ONCOLOGY, 2015, 16 (02): : E53 - E54
  • [46] Epirubicin for adjuvant therapy in node-positive breast cancer
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2000, 42 (1071): : 12 - 13
  • [47] Evaluating lymph node ratio (LNR) as a prognostic indicator in node-positive breast cancer
    Kelliher, A.
    Boyce, M.
    Donnellan, E.
    Connor, D. O.
    Murphy, C.
    Bird, B.
    [J]. CANCER RESEARCH, 2017, 77
  • [48] The recurrence score and chemotherapy treatment in node-positive, ER plus early-stage breast cancer patients in Israel
    Klang, S.
    Liebermann, N.
    Rizel, S.
    Ben-Baruch, N.
    Merling, S.
    Soussan-Gutman, L.
    Bugarini, R.
    Chao, C.
    Shak, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: A Southwest Oncology Group study
    Rivkin, SE
    Green, S
    OSullivan, J
    Cruz, AB
    Abeloff, MD
    Jewell, WR
    Costanzi, JJ
    Farrar, WB
    Osborne, CK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 46 - 51
  • [50] CHEMOTHERAPY VERSUS TAMOXIFEN VERSUS CHEMOTHERAPY PLUS TAMOXIFEN IN NODE-POSITIVE, ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER PATIENTS - RESULTS OF A MULTICENTRIC ITALIAN STUDY
    BOCCARDO, F
    RUBAGOTTI, A
    BRUZZI, P
    CAPPELLINI, M
    ISOLA, G
    NENCI, I
    PIFFANELLI, A
    SCANNI, A
    SISMONDI, P
    SANTI, L
    GENTA, F
    SACCANI, F
    SASSI, M
    MALACARNE, P
    DONATI, D
    FARRIS, A
    CASTAGNETTA, L
    DICARLO, A
    TRAINA, A
    GALLETTO, L
    SMERIERI, F
    BUZZI, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) : 1310 - 1320
12345